Related Experiment Video
Updated: Sep 10, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Triple-Function-Intensified Photoelectric Immunosensing Platform for One-Step Detection of Cardiac Troponin I
Shin-Chwen Yeh1, Wen-Shan Chen1, Wen-Yin Ko1
1Department of Chemistry, National Chung Hsing University, Taichung 402, Taiwan.
This study presents a novel immunosensor for rapid, label-free detection of cardiac troponin I (cTnI). The device uses a unique nanowire-based heterostructure for ultrasensitive and efficient biomarker identification, aiding point-of-care diagnostics.
Area of Science:
- Materials Science
- Nanotechnology
- Biosensing
Background:
- Semiconductor nanowires integrated with nanoplasmonic substrates offer real-time photocurrent responses for immunosensing.
- One-step biorecognition detection of cardiac troponin I (cTnI) remains a significant challenge in current immunosensing platforms.
Purpose of the Study:
- To develop an ultrasensitive immunosensor for one-step, label-free detection of cardiac troponin I (cTnI).
- To create a novel antenna-engaged nanowire-inspired porous heterostructure for enhanced photoelectric performance and signal amplification.
Main Methods:
- Fabrication of a polydopamine-functionalized titanium dioxide nanowire/Au plasmonic layer (PDA/TNW/Au-PL) heterostructure.
- Utilizing interfacial engineering of type II heterojunction and Schottky junction to improve electron-hole separation.
- Employing a nanowire-inspired PDA layer for enhanced charge carrier mobility and direct antibody binding.
Main Results:
- Achieved ultrasensitive, label-free cTnI detection within approximately 30 minutes.
- Demonstrated a wide linear sensing range from 0.001 to 1000 ng mL⁻¹ with an ultralow detection limit of 0.001 ng mL⁻¹.
- The PDA/TNW/Au-PL heterostructure exhibited enhanced light-harvesting efficiency and photoelectric performance.
Conclusions:
- The developed PDA/TNW/Au-PL immunosensor enables rapid, one-step detection of cTnI without secondary antibodies or labels.
- This platform shows significant potential for point-of-care diagnostics, facilitating immediate and accurate therapeutic decision-making.
- The triple-function signal intensification strategy offers a promising approach for developing advanced biosensing technologies.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
08:58Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016